Panel discussion on Regenerative Medicine in the Netherlands
Embassy of the Kingdom of the Netherlands 38 Hyde Park Gate, South Kensington, LondonOn Thursday the 2nd of May our NFIA colleagues in London are organising a panel discussion on why the Netherlands offers an excellent opportunity to scale up your Regenerative Medicine Company. The panel will discuss opportunities for UK companies in Dutch collaborations, and consortia, specifically the realisation of The RegMed XB Pilot Factory, a unique infrastructure that consists of facilities covering the entire chain of development and manufacturing of stem cells, (micro)tissues and smart (bio)materials. The panel will consist of experts from the Dutch nationwide ecosystem: Erik Eijrond, Chief Operating Officer at RegMed XB and coordinator of the realistion of […]
Find out more »